iTAg Tetramer/PE - HLA-A*02:01 Mart-1 (ELAGIGILTV)

MBL

Catalog No: MBL-TS-0009-1

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Citations for iTAg Tetramer/PE - HLA-A*02:01 Mart-1 (ELAGIGILTV) – 8 Found

Inozume, Takashi; Hanada, Ken-Ichi; Takeda, Kazuyo; Maeda, Tatsuo; Harada, Kazutoshi; Kawamura, Tatsuyoshi. Cytotoxic T-lymphocyte-associated protein 4 expressed by melanoma cells does not affect melanoma-specific cytotoxic T lymphocytes in the effector phase. The Journal Of Dermatology. 2019;46(1):52-56. 

Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. 

Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. 

Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. 

Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. 

Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4. 

Takahara, Masashi; Miyai, Manami; Tomiyama, Mai; Mutou, Masato; Nicol, Andrew J; Nieda, Mie. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation. Journal Of Leukocyte Biology. 2008;83(3):742-54. 

Tomiyama, Mai; Takahara, Masashi; Egawa, Kohji; Nieda, Mie. Mature dendritic cells are superior to immature dendritic cells in expanding antigen-specific naive and memory CD8+ T cells. Anticancer Research. 2004;24(5C):3327-33.